LXEO
Lexeo Therapeutics, Inc.
3.50$
-2.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.5% | -2.9% | +4.2% | +2.6% | +2.4% | -3.8% | +1.8% | +3.9% | +73.8% | -96.6% | +206.5% | – | |
| – | -7.9% | +189.9% | +22.1% | +33.2% | -7.5% | +5.4% | -16.9% | -13.7% | +2.3% | +1.5% | +106.5% | – | |
| – | -129.6% | – | -156.3% | – | -186.8% | – | -119.9% | – | – | – | – | – | |
| – | +37.7% | +164.4% | +13.0% | -61.9% | -84.3% | -100.0% | – | +167.6% | -100.0% | – | -80.0% | – | |
| – | +37.7% | +164.4% | +13.0% | -61.9% | +112,650.6% | – | -351.1% | – | -390.4% | – | -48.1% | – | |
| – | – | – | – | – | -130.8% | – | – | – | -200.0% | – | – | – | |
| – | – | – | – | – | +4.5% | +37.1% | -23.3% | -32.0% | +103.6% | -28.4% | +17.4% | – | |
| – | +2,458.1% | -11.4% | -99.7% | -124.7% | +34.7% | – | +663,172.7% | -99.9% | +276,384.6% | -98.3% | +895.1% | – | |
| – | – | -14.4% | -127.3% | – | – | – | – | -16.0% | +298.9% | -60.2% | +140.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.